publication date: Jan. 31, 2014
20140131 - Jan. 31, 2014
ISSUE 5 – JAN. 31, 2014PDF

Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications

Congressional appropriators instructed NIH to cut spending on communications activities and coordinate the broad range of activities that fall under the category of public relations.

The mandate is a part of the report that accompanied the recently passed appropriations bill.

photoIPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment and Outcomes

The International Prevention Research Institute has published “The State of Oncology 2013,” a report that highlights disparate cancer outcomes between higher- and lower-resource countries and proposes long-term recommendations. 

photoPresident Calls For Reversing Cuts to Basic Research Budget

In his state of the union address to Congress Jan. 28, President Barack Obama called for reversing the cuts made to basic research in the federal budget.

photoDrasga, Einhorn Make Appeal For Single-Payer Healthcare

In a feature article published in the Journal of Oncology Practice, oncologists Ray Drasga and Lawrence Einhorn called for their colleagues to endorse single-payer healthcare.

The journal is published by the American Society for Clinical Oncology.

photoACS, SU2C Commit $20 Million For Lung Cancer Dream Team

The American Cancer Society and Stand Up To Cancer announced a collaboration to fund translational research and advocacy programs.

photoIn Brief

  • Indiana University cancer center receives $15 million pledge from Vera Bradley Foundation

  • Hope Funds for Cancer Research announce James D. Watson Award 

  • Dept. of Defense offers $580 million in medical research funding

  • Justin Klamerus named chief quality officer at Karmanos Cancer Institute

  • Angela Davies named chief medical officer of Champions Oncology

  • UCSF and Quest Diagnostics form collaboration

  • John Porter to receive Public Welfare Medal from the National Academy of Sciences

photoFDA News

  • FDA lifts clinical hold on tosedostat

  • U.K. National Institute for Health and Care Excellence issues final opinion on Pixuvri

Copyright (c) 2020 The Cancer Letter Inc.